Reiter syndrome triggered by adalimumab (Humira) and leflunomide (Arava) in a patient with ankylosing spondylarthropathy and Crohn disease.
Thielen
A M
AM
Barde
C
C
Janer
V
V
Borradori
L
L
Saurat
J H
JH
D000068879:Adalimumab; D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D016918:Arthritis, Reactive / Q000139:chemically induced* / Q000150:complications; D003424:Crohn Disease / Q000188:drug therapy*; D006801:Humans; D007555:Isoxazoles / Q000009:adverse effects*; D000077339:Leflunomide; D008297:Male; D025242:Spondylarthropathies / Q000188:drug therapy*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007555:Isoxazoles; D000068879:Adalimumab; D000077339:Leflunomide